Xuewu Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xuewu Liu has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Guixian Zhu
Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX, 77030, USA
5 shared publicationsDechen Zhang
Department of Nanomedicine Houston Methodist Academic Institute 6670 Bertner Avenue 77030 Houston TX USA
4 shared publications- Ennio Tasciotti
Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma University, 00166 Rome, Italy
4 shared publications Gauri Bhave
Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX, 77030, USA
4 shared publications- Haifa Shen
Department of Nanomedicine, Houston Methodist Academic Institute, Houston, TX 77030, USA
4 shared publications - Ning Shao
Center for BioNanoengineering, Houston Methodist Research Institute, Houston, USA
4 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 183
A high-throughput modular microfluidic platform for versatile functional assays at single-cell level
Understanding how individual cells behave is essential for uncovering the complexity of biology and disease, yet most single-cell technologies provide only static molecular snapshots. We present the High-throughput Single-Cell Omni-functional Profiling Engine (HiSCOPE), a microfluidic platform that directly investigates functional dynamics of ≥10,000 single cells. HiSCOPE integrates a hydrodynamic single-cell trapping array with customized modular assay chambers to reproducibly trap single cells, pairs, and trios of cells originating from distinct populations and to support diverse functional assays—including viability, proliferation, cytotoxicity, cytokine secretion, and contact-dependent and -independent cell–cell interactions. Importantly, live-cell retrieval enables downstream analysis of selected cells. We demonstrate HiSCOPE’s utility by evaluating leukemia cells’ drug susceptibility, profiling natural killer (NK) cell cytotoxicity and cytokine secretion, and dissecting T cell–macrophage crosstalk. Our results reveal striking functional diversity that is masked in bulk assays. HiSCOPE offers a scalable solution for functional profiling of single cells, with broad implications for biology, immunotherapy, and personalized medicine. The alternative text for this image may have been generated using AI.
- 18 May 2026
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 12 (1) , 183
Open AccessA high-throughput modular microfluidic platform for versatile functional assays at single-cell level
Understanding how individual cells behave is essential for uncovering the complexity of biology and disease, yet most single-cell technologies provide only static molecular snapshots. We present the High-throughput Single-Cell Omni-functional Profiling Engine (HiSCOPE), a microfluidic platform that directly investigates functional dynamics of ≥10,000 single cells. HiSCOPE integrates a hydrodynamic single-cell trapping array with customized modular assay chambers to reproducibly trap single cells, pairs, and trios of cells originating from distinct populations and to support diverse functional assays—including viability, proliferation, cytotoxicity, cytokine secretion, and contact-dependent and -independent cell–cell interactions. Importantly, live-cell retrieval enables downstream analysis of selected cells. We demonstrate HiSCOPE’s utility by evaluating leukemia cells’ drug susceptibility, profiling natural killer (NK) cell cytotoxicity and cytokine secretion, and dissecting T cell–macrophage crosstalk. Our results reveal striking functional diversity that is masked in bulk assays. HiSCOPE offers a scalable solution for functional profiling of single cells, with broad implications for biology, immunotherapy, and personalized medicine. The alternative text for this image may have been generated using AI.
- Open Access
- 10 April 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (4) , 185
Potentiation of a Porous Silicon Therapeutic Vaccine in Colorectal Cancer via Oxaliplatin-Mediated Regulation of Myeloid-Driven Immunosuppression
Although immunotherapy has shown great promise in treating various types of cancer, advanced tumors are often refractory due to a highly immunosuppressive tumor microenvironment (TME). We previously engineered a cancer therapeutic vaccine platform, µGCVax, by co-loading tumor antigen peptides, STING and TLR9 agonists into porous silicon microparticles. While effective in models with lower disease burden, its efficacy against advanced colorectal cancer (CRC) was less promising due to the accumulation of myeloid-derived suppressor cells (MDSCs) in TMEs. In this study, we investigated whether µGCVax-based immunotherapy in advanced CRCs could be potentiated via regulating MDSCs to reprogram the TME. In an advanced CT26 murine CRC model, we assessed µGCVax in combination with oxaliplatin, a standard CRC chemotherapeutic with established immunomodulatory effects. We demonstrated that oxaliplatin was preferentially taken up by monocytic MDSCs (M-MDSCs) and effectively reduced their abundance in the bone marrow, blood, spleen, and tumor. Relief of this immunosuppressive TME increased intratumoral infiltration of antigen-specific CD8+ T cells. Ultimately, the combination of oxaliplatin with µGCVax induced robust regression of established CRC tumors. These findings highlight that oxaliplatin synergizes with µGCVax by overcoming MDSC-mediated immunosuppression and enhancing antitumor immunity, representing a promising chemo-immunotherapy strategy for advanced CRC.
- 10 April 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (4) , 185
Open AccessPotentiation of a Porous Silicon Therapeutic Vaccine in Colorectal Cancer via Oxaliplatin-Mediated Regulation of Myeloid-Driven Immunosuppression
Although immunotherapy has shown great promise in treating various types of cancer, advanced tumors are often refractory due to a highly immunosuppressive tumor microenvironment (TME). We previously engineered a cancer therapeutic vaccine platform, µGCVax, by co-loading tumor antigen peptides, STING and TLR9 agonists into porous silicon microparticles. While effective in models with lower disease burden, its efficacy against advanced colorectal cancer (CRC) was less promising due to the accumulation of myeloid-derived suppressor cells (MDSCs) in TMEs. In this study, we investigated whether µGCVax-based immunotherapy in advanced CRCs could be potentiated via regulating MDSCs to reprogram the TME. In an advanced CT26 murine CRC model, we assessed µGCVax in combination with oxaliplatin, a standard CRC chemotherapeutic with established immunomodulatory effects. We demonstrated that oxaliplatin was preferentially taken up by monocytic MDSCs (M-MDSCs) and effectively reduced their abundance in the bone marrow, blood, spleen, and tumor. Relief of this immunosuppressive TME increased intratumoral infiltration of antigen-specific CD8+ T cells. Ultimately, the combination of oxaliplatin with µGCVax induced robust regression of established CRC tumors. These findings highlight that oxaliplatin synergizes with µGCVax by overcoming MDSC-mediated immunosuppression and enhancing antitumor immunity, representing a promising chemo-immunotherapy strategy for advanced CRC.
- Open Access
- 1 October 2025
- Published by Faculty of Engineering, University of Kragujevac in Journal of the Serbian Society for Computational Mechanics
- Vol. 19 (1) , 451-462
COMPUTATIONAL MODELING OF DRUG TRANSPORT AND PERFUSION WITHIN COMPLEX BIOLOGICAL SYSTEMS AND GROWING TUMORS
Journal sscm, jsscm, journal of the serbia society for computational mechanics, mechanics, serbia mechanics, journal
- 1 October 2025
- Published by Faculty of Engineering, University of Kragujevac in Journal of the Serbian Society for Computational Mechanics
- Vol. 19 (1) , 451-462
Open AccessCOMPUTATIONAL MODELING OF DRUG TRANSPORT AND PERFUSION WITHIN COMPLEX BIOLOGICAL SYSTEMS AND GROWING TUMORS
Journal sscm, jsscm, journal of the serbia society for computational mechanics, mechanics, serbia mechanics, journal
- 18 June 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 287, 117711
Multiplexed profiling of single-cell secretion on a hierarchical loading microwell chip
- 18 June 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 287, 117711
Multiplexed profiling of single-cell secretion on a hierarchical loading microwell chip
- Open Access
- 1 March 2025
- Published by Tsinghua University Press in Nano Research
- Vol. 18 (3)
Engineered built-in electric fields in Cu 0/CuO x nanozyme-decorated silicon nanodisks for the degradation of phenols and dyes
Laccase has demonstrated potential for the treatment of hazardous pollutants; however, its widespread application is hindered by stability issues. In contrast, nanozymes, with their remarkable stability, present a promising alternative. In this study, we developed silicon-anchored Cu0/CuOx nanozymes exhibiting laccase-like activity for the oxidation removal of phenols and dyes. The valence states of the copper species, which emerged through spontaneous oxidation, played a crucial role in creating a heterogeneous interface, exerting a significant impact on the catalytic efficacy of the copper nanozymes. By employing density functional theory (DFT) calculations, we revealed that the existence of a local built-in electric field (BIEF) among the heterogeneous components facilitated the cyclic consumption of Cu0 and the migration of lattice oxygen. This dynamic interplay modulated the levels of Cu+ and oxygen vacancies (OVs), thereby allowing for sustained catalytic performance within a defined period. Our findings underscore the importance of valence engineering in the rational design of nanozymes and highlight their potential as efficient catalysts for advancing environmental sustainability.
- 1 March 2025
- Published by Tsinghua University Press in Nano Research
- Vol. 18 (3)
Open AccessEngineered built-in electric fields in Cu 0/CuO x nanozyme-decorated silicon nanodisks for the degradation of phenols and dyes
Laccase has demonstrated potential for the treatment of hazardous pollutants; however, its widespread application is hindered by stability issues. In contrast, nanozymes, with their remarkable stability, present a promising alternative. In this study, we developed silicon-anchored Cu0/CuOx nanozymes exhibiting laccase-like activity for the oxidation removal of phenols and dyes. The valence states of the copper species, which emerged through spontaneous oxidation, played a crucial role in creating a heterogeneous interface, exerting a significant impact on the catalytic efficacy of the copper nanozymes. By employing density functional theory (DFT) calculations, we revealed that the existence of a local built-in electric field (BIEF) among the heterogeneous components facilitated the cyclic consumption of Cu0 and the migration of lattice oxygen. This dynamic interplay modulated the levels of Cu+ and oxygen vacancies (OVs), thereby allowing for sustained catalytic performance within a defined period. Our findings underscore the importance of valence engineering in the rational design of nanozymes and highlight their potential as efficient catalysts for advancing environmental sustainability.
- Open Access
- 28 February 2025
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 264, 108699
A parametric study of motion and attachment to capillary walls of circulating tumor cells (CTCs) interacting with non-activated and activated platelets
- 28 February 2025
- Published by Elsevier in Computer Methods and Programs in Biomedicine
- Vol. 264, 108699
Open AccessA parametric study of motion and attachment to capillary walls of circulating tumor cells (CTCs) interacting with non-activated and activated platelets
- Open Access
Silicon Carbide-Gated Nanofluidic Membrane for Active Control of Electrokinetic Ionic Transport
Manipulation of ions and molecules by external control at the nanoscale is highly relevant to biomedical applications. We report a biocompatible electrode-embedded nanofluidic channel membrane designed for electrofluidic applications such as ionic field-effect transistors for implantable drug-delivery systems. Our nanofluidic membrane includes a polysilicon electrode electrically isolated by amorphous silicon carbide (a-SiC). The nanochannel gating performance was experimentally investigated based on the current-voltage (I-V) characteristics, leakage current, and power consumption in potassium chloride (KCl) electrolyte. We observed significant modulation of ionic diffusive transport of both positively and negatively charged ions under physical confinement of nanochannels, with low power consumption. To study the physical mechanism associated with the gating performance, we performed electrochemical impedance spectroscopy. The results showed that the flat band voltage and density of states were significantly low. In light of its remarkable performance in terms of ionic modulation and low power consumption, this new biocompatible nanofluidic membrane could lead to a new class of silicon implantable nanofluidic systems for tunable drug delivery and personalized medicine.
Open AccessSilicon Carbide-Gated Nanofluidic Membrane for Active Control of Electrokinetic Ionic Transport
Manipulation of ions and molecules by external control at the nanoscale is highly relevant to biomedical applications. We report a biocompatible electrode-embedded nanofluidic channel membrane designed for electrofluidic applications such as ionic field-effect transistors for implantable drug-delivery systems. Our nanofluidic membrane includes a polysilicon electrode electrically isolated by amorphous silicon carbide (a-SiC). The nanochannel gating performance was experimentally investigated based on the current-voltage (I-V) characteristics, leakage current, and power consumption in potassium chloride (KCl) electrolyte. We observed significant modulation of ionic diffusive transport of both positively and negatively charged ions under physical confinement of nanochannels, with low power consumption. To study the physical mechanism associated with the gating performance, we performed electrochemical impedance spectroscopy. The results showed that the flat band voltage and density of states were significantly low. In light of its remarkable performance in terms of ionic modulation and low power consumption, this new biocompatible nanofluidic membrane could lead to a new class of silicon implantable nanofluidic systems for tunable drug delivery and personalized medicine.
- Open Access
- 20 August 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (51) , 30840-30847
Enhanced thermal effect of plasmonic nanostructures confined in discoidal porous silicon particles
The design of plasmonic nanostructures could have many exciting applications since it enhances or provides valuable control over efficient energy conversion. A three-dimensional (3D) space is a realistic hotspot matrix harvesting a wide conversion that has been shown in zero-dimensional nanoparticles, one-dimensional linear structures, or two-dimensional films. A novel 3D plasmonic nanostructure platform consisting of plasmonic metal nanoparticles in discoidal porous silicon particles is used in this study. Plasmonic gold nanoparticles are anchored inside the discoidal porous silicon (DPS) particles by in situ reduction synthesis. The novel plasmonic nanostructures can tailor the plasmon band and overcome the instability of photothermal materials. The “trapping well” for the anchored nanoparticles in 3D space can result in a huge change of plasmonic band of metal nanoparticles to the near-IR region in a novel 3D geometry. A multifunctional scaffold, Au–DPS particle, composed of doxorubicin conjugated to poly-(L-glutamic acid) (pDOX), was developed for combinatorial chemo-photothermal cancer therapy. The therapeutic efficacy was examined in treatment of the A549 cell line under near-IR laser irradiation. The highly efficient photothermal conversion can also be demonstrated in the laser desorption/ionization time-of-flight mass spectrometry detection analysis. The limit of detection was obviously improved in the detection of angiotensin II, P14R, and ACTH fragments 18-39 peptides. Overall, we envision that Au–DPS particles may be used in ultrasensitive theranostics in the future.
- 20 August 2020
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 10 (51) , 30840-30847
Open AccessEnhanced thermal effect of plasmonic nanostructures confined in discoidal porous silicon particles
The design of plasmonic nanostructures could have many exciting applications since it enhances or provides valuable control over efficient energy conversion. A three-dimensional (3D) space is a realistic hotspot matrix harvesting a wide conversion that has been shown in zero-dimensional nanoparticles, one-dimensional linear structures, or two-dimensional films. A novel 3D plasmonic nanostructure platform consisting of plasmonic metal nanoparticles in discoidal porous silicon particles is used in this study. Plasmonic gold nanoparticles are anchored inside the discoidal porous silicon (DPS) particles by in situ reduction synthesis. The novel plasmonic nanostructures can tailor the plasmon band and overcome the instability of photothermal materials. The “trapping well” for the anchored nanoparticles in 3D space can result in a huge change of plasmonic band of metal nanoparticles to the near-IR region in a novel 3D geometry. A multifunctional scaffold, Au–DPS particle, composed of doxorubicin conjugated to poly-(L-glutamic acid) (pDOX), was developed for combinatorial chemo-photothermal cancer therapy. The therapeutic efficacy was examined in treatment of the A549 cell line under near-IR laser irradiation. The highly efficient photothermal conversion can also be demonstrated in the laser desorption/ionization time-of-flight mass spectrometry detection analysis. The limit of detection was obviously improved in the detection of angiotensin II, P14R, and ACTH fragments 18-39 peptides. Overall, we envision that Au–DPS particles may be used in ultrasensitive theranostics in the future.
- Open Access
- 19 July 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (7) , 679
Silicon Nanofluidic Membrane for Electrostatic Control of Drugs and Analytes Elution
Individualized long-term management of chronic pathologies remains an elusive goal despite recent progress in drug formulation and implantable devices. The lack of advanced systems for therapeutic administration that can be controlled and tailored based on patient needs precludes optimal management of pathologies, such as diabetes, hypertension, rheumatoid arthritis. Several triggered systems for drug delivery have been demonstrated. However, they mostly rely on continuous external stimuli, which hinder their application for long-term treatments. In this work, we investigated a silicon nanofluidic technology that incorporates a gate electrode and examined its ability to achieve reproducible control of drug release. Silicon carbide (SiC) was used to coat the membrane surface, including nanochannels, ensuring biocompatibility and chemical inertness for long-term stability for in vivo deployment. With the application of a small voltage (≤ 3 V DC) to the buried polysilicon electrode, we showed in vitro repeatable modulation of membrane permeability of two model analytes—methotrexate and quantum dots. Methotrexate is a first-line therapeutic approach for rheumatoid arthritis; quantum dots represent multi-functional nanoparticles with broad applicability from bio-labeling to targeted drug delivery. Importantly, SiC coating demonstrated optimal properties as a gate dielectric, which rendered our membrane relevant for multiple applications beyond drug delivery, such as lab on a chip and micro total analysis systems (µTAS).
- 19 July 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (7) , 679
Open AccessSilicon Nanofluidic Membrane for Electrostatic Control of Drugs and Analytes Elution
Individualized long-term management of chronic pathologies remains an elusive goal despite recent progress in drug formulation and implantable devices. The lack of advanced systems for therapeutic administration that can be controlled and tailored based on patient needs precludes optimal management of pathologies, such as diabetes, hypertension, rheumatoid arthritis. Several triggered systems for drug delivery have been demonstrated. However, they mostly rely on continuous external stimuli, which hinder their application for long-term treatments. In this work, we investigated a silicon nanofluidic technology that incorporates a gate electrode and examined its ability to achieve reproducible control of drug release. Silicon carbide (SiC) was used to coat the membrane surface, including nanochannels, ensuring biocompatibility and chemical inertness for long-term stability for in vivo deployment. With the application of a small voltage (≤ 3 V DC) to the buried polysilicon electrode, we showed in vitro repeatable modulation of membrane permeability of two model analytes—methotrexate and quantum dots. Methotrexate is a first-line therapeutic approach for rheumatoid arthritis; quantum dots represent multi-functional nanoparticles with broad applicability from bio-labeling to targeted drug delivery. Importantly, SiC coating demonstrated optimal properties as a gate dielectric, which rendered our membrane relevant for multiple applications beyond drug delivery, such as lab on a chip and micro total analysis systems (µTAS).
- Open Access
- 26 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (26) , eaba4498
Sequential deconstruction of composite drug transport in metastatic breast cancer
We report a translational toolbox of multiscale imaging and mathematical modeling exploring nanoscale drug transport in metastases.
- 26 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (26) , eaba4498
Open AccessSequential deconstruction of composite drug transport in metastatic breast cancer
We report a translational toolbox of multiscale imaging and mathematical modeling exploring nanoscale drug transport in metastases.